Study of ST266 Given by Intranasal Delivery in Glaucoma Suspect Subjects

NCT03901781 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

9

Enrollment

INDUSTRY

Sponsor class

Conditions

Ocular Hypertension

Interventions

COMBINATION_PRODUCT: ST266 via Intranasal Delivery

Sponsor

Noveome Biotherapeutics, formerly Stemnion